MTT Technology
How does MTT work ?
- Cultured myoblasts repair recipient myoblasts and myofibers genetically and phenotypically by fusion
- Myoblasts are somatic muscle progenitor cells
- Every myoblast is a medicinal chest containing a human genome, organelles and epigenetic factors
- Myoblasts divide extensively without being tumorigenic
- Myoblasts fuse into multinucleated myotubes, lose major histocompatibility Class-I (MHC-1) antigens within 1 week after fusion, and develop into young muscle fibers
- Myoblasts fuse to form multinucleated myotubes, sharing their nuclei
- Myotubes repenish and regenerate myofibers to augment contractile activity
CNN on "Saving Your Life"
Heart disease remains the most common cause of death worldwide. CNN Chief Medical Correspondent Dr. Sanjay Gupta shared a story about experimental myoblast transplant on heart patient.
Copyright © 2025 MyoMed Bio - All Rights Reserved.